Sum and substance in the Jikei Heart Study

Lancet. 2007 Apr 28;369(9571):1407-1408. doi: 10.1016/S0140-6736(07)60643-6.

Authors

Jan A Staessen¹, Tom Richart²

Affiliations

¹ Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, B 3000 Leuven, Belgium. Electronic address: jan.staessen@med.kuleuven.be.
² Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, B 3000 Leuven, Belgium.

PMID: 17467493
DOI: 10.1016/S0140-6736(07)60643-6

No abstract available

Publication types

Comment

MeSH terms

Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Antihypertensive Agents / pharmacology
Antihypertensive Agents / therapeutic use*
Blood Pressure / drug effects
Coronary Disease / drug therapy
Heart Failure / drug therapy
Humans
Hypertension / complications
Hypertension / drug therapy*
Japan
Randomized Controlled Trials as Topic
Renin / blood
Reproducibility of Results
Stroke / etiology

Substances

Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Renin